Neuro Sense Therapeutics Ltd announced it raised $4.47 Million in an initial filing from an offering of $4.47 Million
Apr 25, 2024•about 1 year ago
Amount Raised
$4.47 Million
Round Type
seed
HerzliyaBiotechnology
Company Information
Company
NeuroSense Therapeutics
Location
11 HAMENOFIM STREET, BUILDING B
Herzliya, Tel Aviv, Israel
About
NeuroSense Therapeutics is a clinical-stage biopharmaceutical company, focusing on the discovery and development of targeted innovative therapeutics for neurodegenerative diseases.